Faculdade de Ciências Médicas da Universidade Nova de Lisboa
Lisbon, Portugal
NCT Number: NCT02492217
To identify new candidate genes and proteins that are differentially expressed in responders' vs non-responders to anti-TNF alpha therapy at the several time points the investigators will use the transcriptomic and proteomic analyses. Demonstrate a link between gene expression and protein markers regarding prediction to anti-TNF alpha therapy efficacy.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Phase 4
Lisbon, Portugal
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 14 weeks
To identify anti-TNF alpha clinical response biomarkers by microarrays and proteomics technology.
Time frame: 14 weeks
To evaluate quality of life using ASQOL and SF-36 questionnaires
Time frame: 14 weeks
Rachis evaluation according to acute and structural lesions
Universidade Nova de Lisboa
Other
Biomarkers Identification of Anti-TNF α Agent's Efficacy in Ankylosing Spondylitis Patients Using a Transcriptome Analysis and Mass Spectrometry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00085995
Ankylosing Spondylitis, Ankylosis
Bethesda, Maryland, United States
View Trial DetailsNCT00056719
Ankylosing Spondylitis, Ankylosis
Bethesda, Maryland, United States
View Trial DetailsNCT04673825
Ankylosing Spondylitis, Ankylosis
Maastricht, Limburg, Netherlands
View Trial DetailsNCT04655612
Ankylosing Spondylitis, Ankylosis
Montpellier, Occitanie, France
View Trial Details